These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 28057423)

  • 1. Design, synthesis and biological activities of tetrandrine and fangchinoline derivatives as antitumer agents.
    Li D; Liu H; Liu Y; Zhang Q; Liu C; Zhao S; Jiao B
    Bioorg Med Chem Lett; 2017 Feb; 27(3):533-536. PubMed ID: 28057423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and in vitro evaluation of fangchinoline derivatives as potential anticancer agents.
    Zhang YC; Gao XZ; Liu C; Wang MX; Zhang RR; Sun JY; Liu YF
    Bioorg Chem; 2020 Jan; 94():103431. PubMed ID: 31759658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of new tetrandrine derivatives and their antitumor activities.
    Wei X; Qu TL; Yang YF; Xu JF; Li XW; Zhao ZB; Guo YW
    J Asian Nat Prod Res; 2016 Oct; 18(10):966-75. PubMed ID: 27244089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antitumor activity of tetrandrine derivatives.
    Wu CZ; Lai L; Hu X; Lei RR; Yang YF
    J Asian Nat Prod Res; 2013 Sep; 15(9):993-1002. PubMed ID: 23944846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of novel C
    Lan J; Huang L; Lou H; Chen C; Liu T; Hu S; Yao Y; Song J; Luo J; Liu Y; Xia B; Xia L; Zeng X; Ben-David Y; Pan W
    Eur J Med Chem; 2018 Jan; 143():1968-1980. PubMed ID: 29133049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and in vitro anticancer research of novel tetrandrine and fangchinoline derivatives.
    Gao XZ; Lv XT; Zhang RR; Luo Y; Wang MX; Chen JS; Zhang YK; Sun B; Sun JY; Liu YF; Liu C
    Bioorg Chem; 2021 Apr; 109():104694. PubMed ID: 33601141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of novel tetrandrine derivatives as potential anti-tumor agents against human hepatocellular carcinoma.
    Lan J; Wang N; Huang L; Liu Y; Ma X; Lou H; Chen C; Feng Y; Pan W
    Eur J Med Chem; 2017 Feb; 127():554-566. PubMed ID: 28109948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fangchinoline derivatives induce cell cycle arrest and apoptosis in human leukemia cell lines via suppression of the PI3K/AKT and MAPK signaling pathway.
    Yang J; Hu S; Wang C; Song J; Chen C; Fan Y; Ben-David Y; Pan W
    Eur J Med Chem; 2020 Jan; 186():111898. PubMed ID: 31784186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
    Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
    Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis and Anticancer Evaluation of Fangchinoline Derivatives.
    Liu Y; Xia B; Lan J; Hu S; Huang L; Chen C; Zeng X; Lou H; Lin C; Pan W
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29117113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors.
    Qin YJ; Li YJ; Jiang AQ; Yang MR; Zhu QZ; Dong H; Zhu HL
    Eur J Med Chem; 2015 Apr; 94():447-57. PubMed ID: 25828827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro.
    Chang J; Ren H; Zhao M; Chong Y; Zhao W; He Y; Zhao Y; Zhang H; Qi C
    Eur J Med Chem; 2017 Sep; 138():669-688. PubMed ID: 28711702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 5-Alkynyltetrandrine Derivatives and Evaluation of their Anticancer Activity on A549 Cell Lines.
    Niu N; Qu T; Xu J; Lu X; Bodwell GJ; Zhao Z
    Anticancer Agents Med Chem; 2019; 19(12):1454-1462. PubMed ID: 30961510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of novel benzimidazole-2-substituted phenyl or pyridine propyl ketene derivatives as antitumour agents.
    Wu LT; Jiang Z; Shen JJ; Yi H; Zhan YC; Sha MQ; Wang Z; Xue ST; Li ZR
    Eur J Med Chem; 2016 May; 114():328-36. PubMed ID: 27017265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, Synthesis of Novel Tetrandrine-14-l-Amino Acid and Tetrandrine-14-l-Amino Acid-Urea Derivatives as Potential Anti-Cancer Agents.
    Hu SC; Yang J; Chen C; Song JR; Pan WD
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32283819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
    Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
    Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of novel 3-substituted 4-anilino-coumarin derivatives as antitumor agents.
    Luo G; Muyaba M; Lyu W; Tang Z; Zhao R; Xu Q; You Q; Xiang H
    Bioorg Med Chem Lett; 2017 Feb; 27(4):867-874. PubMed ID: 28110871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of novel quinazoline nitrogen mustard derivatives as potential therapeutic agents for cancer.
    Li S; Wang X; He Y; Zhao M; Chen Y; Xu J; Feng M; Chang J; Ning H; Qi C
    Eur J Med Chem; 2013 Sep; 67():293-301. PubMed ID: 23871909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of novel pyrenyl derivatives as anticancer agents.
    Bandyopadhyay D; Sanchez JL; Guerrero AM; Chang FM; Granados JC; Short JD; Banik BK
    Eur J Med Chem; 2015 Jan; 89():851-62. PubMed ID: 25462285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of 4-amino-5-cinnamoylthiazoles as chalcone-like anticancer agents.
    Ayati A; Esmaeili R; Moghimi S; Oghabi Bakhshaiesh T; Eslami-S Z; Majidzadeh-A K; Safavi M; Emami S; Foroumadi A
    Eur J Med Chem; 2018 Feb; 145():404-412. PubMed ID: 29335206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.